GTPBP6
gene geneOn this page
Also known as PGPLFLJ20977
Summary
GTPBP6 (GTP binding protein 6, HGNC:30189) is a protein-coding gene on chromosome Xp22.33 and Yp11.32, encoding Putative GTP-binding protein 6 (O43824).
This gene encodes a GTP binding protein and is located in the pseudoautosomal region (PAR) at the end of the short arms of the X and Y chromosomes.
Source: NCBI Gene 8225 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 1 total
- MANE Select transcript:
NM_012227
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30189 |
| Approved symbol | GTPBP6 |
| Name | GTP binding protein 6 |
| Location | Xp22.33 and Yp11.32 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | PGPL, FLJ20977 |
| Ensembl gene | ENSG00000178605 |
| Ensembl biotype | protein_coding |
| OMIM | 300124 |
| Entrez | 8225 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 7 protein_coding, 1 retained_intron
ENST00000326153, ENST00000485332, ENST00000850592, ENST00000900013, ENST00000900014, ENST00000900015, ENST00000914511, ENST00000966877
RefSeq mRNA: 1 — MANE Select: NM_012227
NM_012227
CCDS: CCDS75943
Canonical transcript exons
ENST00000326153 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001288218 | 311419 | 311627 |
| ENSE00001793174 | 312766 | 312924 |
| ENSE00003449454 | 314150 | 314217 |
| ENSE00003581203 | 307360 | 307512 |
| ENSE00003654058 | 307732 | 307880 |
| ENSE00003714129 | 314890 | 315020 |
| ENSE00003733507 | 316914 | 317051 |
| ENSE00003733593 | 315229 | 315299 |
| ENSE00004282261 | 304759 | 305197 |
| ENSE00004282262 | 318439 | 318796 |
Expression profiles
Bgee: expression breadth ubiquitous, 251 present calls, max score 95.74.
Top tissues by expression
279 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left ovary | UBERON:0002119 | 95.74 | gold quality |
| right ovary | UBERON:0002118 | 95.70 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 95.68 | gold quality |
| tibial nerve | UBERON:0001323 | 95.01 | gold quality |
| body of stomach | UBERON:0001161 | 94.93 | gold quality |
| gastrocnemius | UBERON:0001388 | 94.87 | gold quality |
| body of uterus | UBERON:0009853 | 94.82 | gold quality |
| sural nerve | UBERON:0015488 | 94.59 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 94.55 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 94.45 | gold quality |
| cerebellar cortex | UBERON:0002129 | 94.42 | gold quality |
| left uterine tube | UBERON:0001303 | 94.30 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 94.24 | gold quality |
| right uterine tube | UBERON:0001302 | 94.22 | gold quality |
| lower esophagus | UBERON:0013473 | 94.22 | gold quality |
| left coronary artery | UBERON:0001626 | 94.17 | gold quality |
| muscle of leg | UBERON:0001383 | 94.13 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 94.07 | gold quality |
| metanephros cortex | UBERON:0010533 | 94.07 | gold quality |
| body of pancreas | UBERON:0001150 | 94.04 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 94.02 | gold quality |
| endocervix | UBERON:0000458 | 94.01 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 93.98 | gold quality |
| right lung | UBERON:0002167 | 93.96 | gold quality |
| popliteal artery | UBERON:0002250 | 93.96 | gold quality |
| tibial artery | UBERON:0007610 | 93.95 | gold quality |
| right atrium auricular region | UBERON:0006631 | 93.90 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 93.84 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 93.77 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 93.77 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
8 targeting GTPBP6, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3173-3P | 99.98 | 66.49 | 1217 |
| HSA-MIR-6891-5P | 99.98 | 66.53 | 1372 |
| HSA-MIR-551B-5P | 99.96 | 71.28 | 3493 |
| HSA-MIR-3934-3P | 99.76 | 65.51 | 1351 |
| HSA-MIR-4505 | 99.27 | 67.81 | 2678 |
| HSA-MIR-5787 | 99.22 | 67.86 | 2628 |
| HSA-MIR-7977 | 98.65 | 66.18 | 2590 |
| HSA-MIR-6090 | 91.01 | 62.65 | 222 |
Literature-anchored findings (GeneRIF, showing 1)
- Dual function of GTPBP6 in biogenesis and recycling of human mitochondrial ribosomes. (PMID:33264405)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | gtpbp6 | ENSDARG00000061091 |
| mus_musculus | Gtpbp6 | ENSMUSG00000033434 |
| rattus_norvegicus | Gtpbp6 | ENSRNOG00000062521 |
| drosophila_melanogaster | CG5116 | FBGN0039339 |
Protein
Protein identifiers
Putative GTP-binding protein 6 — O43824 (reviewed: O43824)
Alternative names: Pseudoautosomal GTP-binding protein-like
All UniProt accessions (1): O43824
UniProt curated annotations — full annotation on UniProt →
Tissue specificity. Ubiquitously expressed.
Miscellaneous. The gene coding for this protein is located in the pseudoautosomal region 1 (PAR1) of X and Y chromosomes.
Similarity. Belongs to the TRAFAC class OBG-HflX-like GTPase superfamily. HflX GTPase family.
RefSeq proteins (1): NP_036359* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR006073 | GTP-bd | Domain |
| IPR016496 | GTPase_HflX | Family |
| IPR025121 | GTPase_HflX_N | Domain |
| IPR027417 | P-loop_NTPase | Homologous_superfamily |
| IPR030394 | G_HFLX_dom | Domain |
| IPR032305 | GTP-bd_M | Domain |
| IPR042108 | GTPase_HflX_N_sf | Homologous_superfamily |
Pfam: PF01926, PF13167, PF16360
UniProt features (18 total): binding site 7, sequence conflict 5, compositionally biased region 3, chain 1, domain 1, region of interest 1
Structure
Experimental structures (PDB)
3 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7OF6 | ELECTRON MICROSCOPY | 2.6 |
| 7OF2 | ELECTRON MICROSCOPY | 2.7 |
| 7OF4 | ELECTRON MICROSCOPY | 2.7 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O43824-F1 | 77.92 | 0.38 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (7): 349–352; 418–421; 437–439; 301–308; 308; 327–331; 329
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 98 (showing top):
GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_UP, GOBP_RIBOSOME_BIOGENESIS, GOBP_RIBOSOME_ASSEMBLY, GOBP_RIBOSOMAL_LARGE_SUBUNIT_ASSEMBLY, BLALOCK_ALZHEIMERS_DISEASE_UP, GOBP_PROTEIN_RNA_COMPLEX_ORGANIZATION, GOBP_ORGANELLE_ASSEMBLY, GOBP_RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS, GOBP_RIBOSOMAL_LARGE_SUBUNIT_BIOGENESIS, SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN, SANSOM_APC_TARGETS_REQUIRE_MYC, NUYTTEN_NIPP1_TARGETS_DN, MODULE_159, GOMF_RIBONUCLEOPROTEIN_COMPLEX_BINDING, GOMF_RIBOSOME_BINDING
GO Biological Process (1): mitochondrial large ribosomal subunit assembly (GO:1902775)
GO Molecular Function (5): GTP binding (GO:0005525), ribosome binding (GO:0043022), ribosomal large subunit binding (GO:0043023), metal ion binding (GO:0046872), nucleotide binding (GO:0000166)
GO Cellular Component (2): cytoplasm (GO:0005737), mitochondrion (GO:0005739)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| ribosomal large subunit assembly | 1 |
| mitochondrial ribosome assembly | 1 |
| guanyl ribonucleotide binding | 1 |
| purine ribonucleoside triphosphate binding | 1 |
| ribonucleoprotein complex binding | 1 |
| ribosome binding | 1 |
| cation binding | 1 |
| nucleoside phosphate binding | 1 |
| heterocyclic compound binding | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
1694 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GTPBP6 | GTPBP4 | Q9BZE4 | 832 |
| GTPBP6 | MALSU1 | Q96EH3 | 769 |
| GTPBP6 | GTPBP10 | A4D1E9 | 763 |
| GTPBP6 | PLCXD1 | Q9NUJ7 | 754 |
| GTPBP6 | MTG2 | Q9H4K7 | 747 |
| GTPBP6 | ASMTL | O95671 | 728 |
| GTPBP6 | PPP2R3B | Q9Y5P8 | 698 |
| GTPBP6 | DDX28 | Q9NUL7 | 691 |
| GTPBP6 | MTG1 | Q9BT17 | 690 |
| GTPBP6 | GTPBP8 | Q8N3Z3 | 667 |
| GTPBP6 | AKAP17A | Q02040 | 666 |
| GTPBP6 | DHRSX | Q8N5I4 | 630 |
| GTPBP6 | MTERF4 | Q7Z6M4 | 616 |
| GTPBP6 | NSUN4 | Q96CB9 | 602 |
| GTPBP6 | MRRF | Q96E11 | 595 |
IntAct
44 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CD79A | METTL15 | psi-mi:“MI:0914”(association) | 0.530 |
| SDF4 | GTPBP6 | psi-mi:“MI:0914”(association) | 0.530 |
| BPNT1 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| YBEY | NME4 | psi-mi:“MI:0914”(association) | 0.530 |
| PSME1 | POLR3A | psi-mi:“MI:0914”(association) | 0.530 |
| ATP5F1D | NDUFB5 | psi-mi:“MI:0914”(association) | 0.530 |
| EMILIN1 | METTL15 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNRD2 | CCDC85C | psi-mi:“MI:0914”(association) | 0.530 |
| GTPBP6 | RPL24 | psi-mi:“MI:0915”(physical association) | 0.400 |
| Rpl35 | RPS6 | psi-mi:“MI:0914”(association) | 0.350 |
| RIPK4 | VWA8 | psi-mi:“MI:0914”(association) | 0.350 |
| ESR1 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| MRPL12 | psi-mi:“MI:0914”(association) | 0.350 | |
| AP3B1 | psi-mi:“MI:0914”(association) | 0.350 | |
| ATG16L1 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| ATG16L1 | psi-mi:“MI:0914”(association) | 0.350 | |
| HLA-DRA | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
| PIPSL | C1orf226 | psi-mi:“MI:0914”(association) | 0.350 |
| LURAP1 | CIBAR1 | psi-mi:“MI:0914”(association) | 0.350 |
| MAGEA9 | CIBAR1 | psi-mi:“MI:0914”(association) | 0.350 |
| FAXC | METTL15 | psi-mi:“MI:0914”(association) | 0.350 |
| DGCR2 | CCDC85C | psi-mi:“MI:0914”(association) | 0.350 |
| DKK3 | MYO9A | psi-mi:“MI:0914”(association) | 0.350 |
| THBS3 | APBB1 | psi-mi:“MI:0914”(association) | 0.350 |
| MRPS17 | POLRMT | psi-mi:“MI:0914”(association) | 0.350 |
| MRPL23 | GTPBP6 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (86): GTPBP6 (Affinity Capture-MS), GTPBP6 (Affinity Capture-MS), GTPBP6 (Affinity Capture-MS), GTPBP6 (Affinity Capture-MS), GTPBP6 (Affinity Capture-MS), GTPBP6 (Affinity Capture-MS), GTPBP6 (Affinity Capture-MS), GTPBP6 (Affinity Capture-MS), GTPBP6 (Affinity Capture-MS), GTPBP6 (Affinity Capture-MS), GTPBP6 (Affinity Capture-MS), GTPBP6 (Affinity Capture-RNA), GTPBP6 (Affinity Capture-RNA), GTPBP6 (Affinity Capture-MS), GTPBP6 (Affinity Capture-MS)
ESM2 similar proteins: A0A1B3PEJ0, A0A2K3DU55, A2XFU5, A2XU53, A2YQ58, A4HUY0, A4I1F7, A4RPM5, A8I2V9, B6TN12, B8A031, B8AA76, B8B016, B9FK36, C0PN26, C5XKZ1, C5Y9R0, E1BRE2, E2RDZ6, O43824, P18080, P52506, P52507, P84172, Q0D3F2, Q0J705, Q10MI9, Q2KIF8, Q2KNB4, Q2QMG2, Q3U6U5, Q5AQE4, Q5R6G3, Q5ZAQ2, Q5ZHX9, Q6H4G3, Q6L534, Q6NZB1, Q6Z4A7, Q74ZW4
Diamond homologs: A0L4B2, A0LPF9, A1RY30, A2BLW4, A5EY43, A5GNK6, A5IKX2, A6H294, A6TQJ6, A7HIF8, A8FRU4, A9A623, A9H253, B0K414, B0KAB8, B0T310, B1I5V8, B1KGH1, B1LA53, B1ZZ37, B2FNR1, B2U9V3, B2UPE7, B3QZ96, B3R1J8, B4RD64, B4SSW8, B4UIU2, B5EJF7, B7JC34, B8FUR9, B8I179, B8JBP2, B9DNE7, B9KZ43, C0QLE9, C1F407, C5BLV6, C6E2H7, D3FTV4
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 57 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Translation | 6 | 10.6× | 4e-03 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| translation | 6 | 12.3× | 3e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
1 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
761 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:305211:CGCGT:C | acceptor_gain | 1.0000 |
| X:305213:CGT:C | acceptor_gain | 1.0000 |
| X:305215:T:C | acceptor_gain | 1.0000 |
| X:305215:T:TC | acceptor_gain | 1.0000 |
| X:307355:CTCA:C | donor_loss | 1.0000 |
| X:307356:TCA:T | donor_loss | 1.0000 |
| X:307357:CACCT:C | donor_loss | 1.0000 |
| X:307358:AC:A | donor_loss | 1.0000 |
| X:307728:TCA:T | donor_loss | 1.0000 |
| X:307729:CACCC:C | donor_loss | 1.0000 |
| X:307730:AC:A | donor_gain | 1.0000 |
| X:307731:CC:C | donor_gain | 1.0000 |
| X:305194:CCAG:C | acceptor_gain | 0.9900 |
| X:305195:CAGC:C | acceptor_gain | 0.9900 |
| X:305196:A:T | acceptor_gain | 0.9900 |
| X:305205:CAGA:C | acceptor_gain | 0.9900 |
| X:305208:A:AC | acceptor_gain | 0.9900 |
| X:305208:A:C | acceptor_gain | 0.9900 |
| X:305214:G:GC | acceptor_gain | 0.9900 |
| X:305217:G:GC | acceptor_gain | 0.9900 |
| X:305219:A:AC | acceptor_gain | 0.9900 |
| X:305219:A:C | acceptor_gain | 0.9900 |
| X:307508:TGTAC:T | acceptor_gain | 0.9900 |
| X:307510:TAC:T | acceptor_gain | 0.9900 |
| X:307511:AC:A | acceptor_gain | 0.9900 |
| X:307512:CC:C | acceptor_gain | 0.9900 |
| X:307513:C:CC | acceptor_gain | 0.9900 |
| X:307513:C:CG | acceptor_loss | 0.9900 |
| X:307514:T:C | acceptor_loss | 0.9900 |
| X:307730:A:AC | donor_gain | 0.9900 |
AlphaMissense
6586 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| Y:311563:A:C | F327L | 0.993 |
| Y:311563:A:T | F327L | 0.993 |
| Y:311565:A:G | F327L | 0.993 |
| Y:311449:G:C | F365L | 0.992 |
| Y:311449:G:T | F365L | 0.992 |
| Y:311451:A:G | F365L | 0.992 |
| Y:305181:C:G | A482P | 0.991 |
| Y:311485:G:C | F353L | 0.991 |
| Y:311485:G:T | F353L | 0.991 |
| Y:311487:A:G | F353L | 0.991 |
| Y:307749:C:A | K419N | 0.989 |
| Y:307749:C:G | K419N | 0.989 |
| Y:311486:A:G | F353S | 0.989 |
| Y:312780:C:T | G301E | 0.989 |
| Y:315266:A:T | V174D | 0.989 |
| Y:311565:A:T | F327I | 0.988 |
| Y:311627:C:T | G306E | 0.988 |
| Y:311564:A:C | F327C | 0.985 |
| Y:311627:C:A | G306V | 0.985 |
| Y:312781:C:G | G301R | 0.985 |
| Y:312781:C:T | G301R | 0.985 |
| Y:315002:A:G | W193R | 0.985 |
| Y:315002:A:T | W193R | 0.985 |
| Y:317031:C:G | A124P | 0.985 |
| Y:305174:A:T | V484D | 0.984 |
| Y:311499:C:G | D349H | 0.984 |
| Y:311623:C:A | K307N | 0.984 |
| Y:311623:C:G | K307N | 0.984 |
| Y:314944:G:T | A212D | 0.984 |
| Y:311498:T:A | D349V | 0.983 |
dbSNP variants (sampled 300 via entrez): RS1000079997 (X:307386 A>G), RS1000157476 (X:310832 A>G), RS1000637681 (X:310951 G>A,C), RS1000675767 (X:306377 C>T), RS1001171690 (X:306183 G>A), RS1001798100 (X:306138 A>C,G), RS1002005441 (X:309641 C>T), RS1002516783 (X:309382 T>C), RS1002580836 (X:313229 C>T), RS1002909325 (X:305375 G>A,C), RS1002940360 (X:305481 C>G), RS1003112505 (X:308590 G>A,C), RS1003427511 (X:308774 A>G), RS1004146563 (X:308515 C>T), RS1005802417 (X:304472 A>G,T)
Disease associations
OMIM: gene MIM:300124 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
25 total (human), top 25 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, increases expression | 3 |
| chromium hexavalent ion | increases expression, decreases expression, increases abundance | 2 |
| Cadmium Chloride | increases expression | 2 |
| trichostatin A | affects expression | 1 |
| zinc chromate | decreases expression, increases abundance | 1 |
| potassium chromate(VI) | increases expression | 1 |
| cupric chloride | increases expression | 1 |
| nickel sulfate | increases expression | 1 |
| 2,3-dimethoxy-1,4-naphthoquinone | increases expression | 1 |
| theaflavin-3,3’-digallate | affects expression | 1 |
| Air Pollutants | increases abundance, affects expression | 1 |
| Antimony | increases expression | 1 |
| Antimony Potassium Tartrate | increases expression | 1 |
| Cadmium | increases expression | 1 |
| Cisplatin | decreases expression | 1 |
| Estradiol | decreases expression | 1 |
| Methyl Methanesulfonate | decreases expression | 1 |
| Ouabain | increases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Potassium Dichromate | increases expression | 1 |
| Ribonucleotides | affects binding | 1 |
| Smoke | decreases expression | 1 |
| Toluene | decreases methylation, increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Sodium Selenite | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.